American Uranium Limited Announces Issuance of 114,583 Shares Under Section 708A Exemption

Section 708A Relief Explained and Its Use in American Uranium's Share Issue

American Uranium Limited utilized section 708A(5)(e) of the Corporations Act for its 22 July 2026 share issuance, allowing the company to issue securities without a formal disclosure document under Part 6D.2. This relief is commonly used by ASX-listed companies to facilitate capital raising and share issuance efficiently when specific compliance criteria are met. The provision mandates notifying the ASX and certifying ongoing compliance with key regulatory obligations, ensuring transparency within Australia's corporate regulatory framework.

The company's reliance on this exemption indicates compliance with relevant requirements at issuance, including continuous disclosure obligations under Chapter 2M of the Corporations Act. By lodging Appendix 2A with the ASX, American Uranium fulfilled its notification duties, creating a public record of the transaction. This approach balances streamlined capital management with investor protections by maintaining adherence to existing continuous disclosure and financial reporting standards without requiring a separate disclosure document.

Details of the 114,583 Shares Issued and Their ASX Quotation Status

The 114,583 ordinary fully paid shares issued form part of a class of securities officially quoted on the ASX, enabling trading on the secondary market. These shares carry the same rights and obligations as existing ordinary shares and are eligible for subsequent sale, subject to any contractual or escrow restrictions. The quotation status ensures these securities comply with ASX listing rules and continuous disclosure requirements, providing liquidity and transparency to investors.

The issuance was formally documented through the Appendix 2A lodgement, establishing an auditable record within ASX regulatory systems. This transaction reflects a specific capital management activity by American Uranium.

Compliance with Corporations Act and Regulatory Framework

American Uranium confirmed compliance with Chapter 2M of the Corporations Act as of the notice date, which mandates immediate disclosure of material information affecting the value of securities. This compliance is essential for maintaining ASX listing status and investor confidence, demonstrating the company's commitment to transparent governance.

Additionally, the company affirmed adherence to sections 674 and 674A of the Corporations Act, relating to timely financial reporting and lodgement with the ASX. This confirms that American Uranium’s financial records and reporting processes meet Australian accounting standards and regulatory deadlines, reinforcing investor assurance regarding the company’s regulatory compliance.

Certification of No Excluded Information at Issuance

American Uranium notified the ASX that no "excluded information"—as defined in sections 708A(7) and (8) of the Corporations Act—exists that would require disclosure. Excluded information encompasses material, non-public details that could influence investment decisions. This certification confirms that all material information has been disclosed, ensuring the section 708A relief was appropriately applied without withholding significant facts from the market.

This assurance supports the integrity of the share issuance process and maintains the credibility of the company’s regulatory filings.

Appendix 2A Filing and ASX Notification Compliance

American Uranium lodged an Appendix 2A form with the ASX detailing the securities issued on 22 July 2026. This mandatory filing accompanies share issuances without a prospectus, disclosing the number of shares, issue date, restrictions, and issuance basis. The filing creates a transparent public record accessible via the ASX website.

By adhering to these notification procedures and issuing the formal notice under section 708A(5)(e), American Uranium complies with ASX listing rules and continuous disclosure requirements, ensuring timely and standardized market communication regarding capital transactions.

Company Overview and Market Position

American Uranium Limited is a Perth-based mineral exploration and development firm focused on uranium, a vital resource for nuclear energy. Located at 104 Colin Street, West Perth, the company engages actively with investors and stakeholders. The uranium sector has garnered attention amid global energy transitions and growing demand for low-carbon energy, positioning American Uranium to benefit from expanding nuclear capacity and uranium demand forecasts.

Listed on the ASX, the company accesses capital markets for funding through share issuances like the recent transaction. ASX listing subjects American Uranium to continuous disclosure and governance rules, ensuring accountability. The uranium sector’s inherent risks include exploration uncertainty, commodity price fluctuations, and regulatory compliance, factors investors should consider alongside operational and market developments.

Implications for Investors and Market Impact

The issuance of 114,583 shares may affect existing shareholders through potential dilution and earnings per share changes, depending on total capital structure and issuance context. The lack of a prospectus suggests shares were likely issued to existing investors, employees, or related parties. These shares’ eligibility for subsequent sale means they could enter the market, potentially influencing share price and liquidity based on volume and timing.

No immediate share price impact was publicly available. Investors should review accompanying announcements and financial reports for comprehensive context. The section 708A regulatory framework permits such issuances without full disclosure when continuous disclosure and financial reporting obligations are met, as confirmed by American Uranium.

Authorisation and Governance

This company update was authorised by Matthew Foy, Company Secretary of American Uranium Limited. The Company Secretary ensures compliance with ASX listing rules and the Corporations Act, confirming that the notice is accurate and properly approved. This governance structure promotes accountability and regulatory adherence, providing investors with confidence in the integrity of the company’s disclosures.

Future Outlook and Regulatory Responsibilities

American Uranium remains obligated to comply with continuous disclosure rules, timely financial reporting, and prompt market notifications of material developments. The company continues to operate under ASX listing rules and the Corporations Act, with investors advised to monitor announcements related to exploration results, project updates, financing, and operational changes.

Contact information, including phone, email, and website details, is provided in the regulatory notice for investor inquiries. The company’s registered office at 104 Colin Street, West Perth, serves as a point of contact. American Uranium’s performance and share price will be influenced by exploration success, uranium market conditions, and regulatory developments within the nuclear energy sector. Investors should conduct thorough research and seek professional advice before investing.